about
P3578
Systematic variation in gene expression patterns in human cancer cell linesHigh resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMinerThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityA genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancersDNA fingerprinting of the NCI-60 cell line panel.Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysIdentification of cancer cell-line origins using fluorescence image-based phenomic screening.The metabolic demands of cancer cells are coupled to their size and protein synthesis ratesNational Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testingCell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.Classification and biological nature of established human hematopoietic cell lines.Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferationThe exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCRA landscape of pharmacogenomic interactions in cancer.Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.A map of mobile DNA insertions in the NCI-60 human cancer cell panel.Global proteome analysis of the NCI-60 cell line panel.Telomere analysis by fluorescence in situ hybridization and flow cytometryAuthenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines.Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines.DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines.Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.Immunophenotypic and cytogenetic analysis of Molt-3 and Molt-4: human T-lymphoid cell lines with rearrangement of chromosome 7.[Genetic characteristics of human acute lymphoblastic leukemia cell line Molt-4].Interferon system defects in malignant T-cells.Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
P4510
Q54903593-386C3A18-3110-4EBF-9B32-D3F1031915DDQ54906366-2D11128A-4266-4C80-A43E-F26CCEB4C735Q54906367-747A925A-5F88-4B35-85F0-B9E2ECCF1424Q54906368-85034A2D-ECF9-4C53-A339-4A5135559E13Q54906370-D8DD362A-FDAA-4B8C-AA93-FEBB65D99A16Q54906371-F4E8E368-EE6F-4C7F-A185-DCFF0F6B42B2Q54930508-196C3B15-E8AD-44C9-A6B9-606943DAEF02
P3432
Q28145747-9126970D-E24B-4124-A7BC-D05ED79B1AE6Q28541555-C22AFE27-40EF-485C-A130-3C40312507A3Q29547693-FDA255D9-4319-47A8-B9C8-1182FDADC83AQ30434796-159343B7-7979-4061-9CAA-93F2209050EFQ33608214-6A78DE21-7D2F-40F7-894E-8D97317290B2Q33882864-17DA3D5C-B43D-41E5-88E1-56C4091542C7Q34182256-42F86522-0ABC-4EB9-B534-57104FC1FCBFQ34258905-14206561-ED50-4EB0-85FE-BCE94268C1B4Q34422537-FFF5BEA1-DC5D-4A48-81D9-8A878F1A333FQ36247943-140C4225-A5E2-4503-BA4E-9079168CA967Q36412966-D44BB2AF-BB89-4B9B-95BA-2F6DD38C842FQ36477750-D2836CB0-5E49-4B72-BEBB-BFE06FA04543Q36971433-9038BD8F-804E-4CAF-A167-701A41161C4EQ37064887-7170483E-F762-41B0-BCA5-3E46B2E2A68BQ37140236-D658B2FD-7F73-4DC4-925B-003FF05892BDQ37250634-609FFD64-7A5C-4FF3-8021-5B431BDCA92DQ37380123-30052EF8-05BD-4E8A-AF9E-FF30D90AD735Q39112561-82A396E9-6C8C-42B5-AC62-DA0AFDAC1655Q39724762-A4264228-821F-4AB1-9149-46CBE1626350Q40206072-79F1CD1B-4855-46FA-B7D4-0D1A9279E986Q40330808-C97C99C5-3735-496E-8984-180C600D42A1Q40734731-A01803AE-E88A-4089-B709-5F9CE366571BQ40850895-3C722B22-F0AC-4017-BA21-78C754DDE34CQ40968306-5A459B73-EFFB-4841-BFA7-BAD86A893F16Q41202708-EF94DE37-0E66-4DBB-9390-4F5CB0EC8DF3Q41551085-F25BD9F7-E7AF-4716-9259-AE91A2EA75A9Q41679901-D65EE7A0-F69A-41BC-A104-45F962C6F16EQ42810721-D80471AA-F6AD-4613-85B6-A7F851F1ECB6Q42817746-1C4858E3-8935-4288-9240-20752B3111D5Q42825939-FA1479EF-F232-479E-9EE2-F7E842A4174BQ52826947-0025B9CE-F05F-469A-A4F2-A099D6FF5DE5Q52833018-DE3CD917-E18D-4936-BED8-5C68A4470809Q52833019-5948F768-D39B-404B-A52B-9225DA2D9926
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
linhagem celular
@pt
name
MOLT-4
@de
MOLT-4
@en
MOLT-4
@fr
MOLT-4
@ga
MOLT-4
@nl
MOLT-4
@pt
type
label
MOLT-4
@de
MOLT-4
@en
MOLT-4
@fr
MOLT-4
@ga
MOLT-4
@nl
MOLT-4
@pt
altLabel
GM02219
@en
GM02219C
@en
GM02219D
@en
GM2219C
@en
MOLT 4
@en
MOLT.4
@en
MOLT4
@en
Molt-4
@en
prefLabel
MOLT-4
@de
MOLT-4
@en
MOLT-4
@fr
MOLT-4
@ga
MOLT-4
@nl
MOLT-4
@pt